Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Idexx Laboratories
IDXX
$43.9B
| $98.7M | 0.05% |
395,410
+69,128
| +21% | +$16.8M |
|
|
GRMN
402
Garmin
GRMN
$46.8B
| $98.7M | 0.05% |
1,409,095
-385
| -0% | -$25.2K |
|
403
Extra Space Storage
EXR
$31.4B
| $98.7M | 0.05% |
1,139,069
+812,925
| +249% | +$75.5M |
|
404
Puma Biotechnology
PBYI
$410M
| $98.4M | 0.05% |
2,146,460
-1,155,561
| -35% | -$55.7M |
|
405
Lincoln Electric
LECO
$14.1B
| $98.2M | 0.05% |
1,050,406
+30
| +0% | +$2.77K |
|
406
Expedia Group
EXPE
$33.4B
| $98.1M | 0.05% |
751,824
+185,877
| +33% | +$24.1M |
|
407
AMC Entertainment Holdings
AMC
$2.21B
| $97.7M | 0.05% |
476,773
-4,066
| -0.8% | -$736K |
|
408
Robert Half
RHI
$4.04B
| $97.3M | 0.05% |
1,382,612
+337,202
| +32% | +$24.7M |
|
409
UBS Group
UBS
$172B
| $96.7M | 0.05% |
6,096,483
+480,898
| +9% | +$7.56M |
|
410
eBay
EBAY
$50.3B
| $96.4M | 0.05% |
2,918,671
-674,358
| -19% | -$23.4M |
|
|
WMGI
411
DELISTED
Wright Medical Group Inc
WMGI
| $95.9M | 0.05% |
3,305,277
+612,326
| +23% | +$16.5M |
|
412
Trip.com Group
TCOM
$28.2B
| $94.9M | 0.05% |
2,552,893
-160,598
| -6% | -$6.52M |
|
413
Baidu
BIDU
$35.8B
| $94.8M | 0.05% |
414,589
+72,258
| +21% | +$17M |
|
414
Cooper-Standard Automotive
CPS
$509M
| $94.2M | 0.05% |
785,516
+41,828
| +6% | +$5.61M |
|
415
NeoGenomics
NEO
$1.71B
| $93.7M | 0.05% |
6,104,475
-53,730
| -0.9% | -$743K |
|
416
Generac Holdings
GNRC
$11.6B
| $93.5M | 0.05% |
1,657,690
-216,836
| -12% | -$11.9M |
|
417
BioCryst Pharmaceuticals
BCRX
$2.45B
| $93.5M | 0.05% |
12,250,161
+1,153,978
| +10% | +$7.75M |
|
418
Hanover Insurance
THG
$7.7B
| $92.7M | 0.05% |
751,288
-24,246
| -3% | -$2.99M |
|
419
CVS Health
CVS
$137B
| $92.3M | 0.05% |
1,171,895
+555,880
| +90% | +$39.7M |
|
420
DaVita
DVA
$15.1B
| $91.5M | 0.05% |
1,277,658
-6,434
| -0.5% | -$455K |
|
421
Wendy's
WEN
$1.4B
| $91.3M | 0.05% |
5,328,776
-270,405
| -5% | -$4.72M |
|
422
Dell
DELL
$276B
| $91.2M | 0.05% |
3,346,262
-1,300,386
| -28% | -$34.7M |
|
423
Trade Desk
TTD
$8.43B
| $91.2M | 0.05% |
6,041,230
-2,765,190
| -31% | -$32.8M |
|
|
AABA
424
DELISTED
Altaba Inc
AABA
| $90.7M | 0.05% |
1,331,906
-17,985
| -1% | -$1.27M |
|
425
Okta
OKTA
$23.9B
| $90.3M | 0.05% |
1,284,039
+142,335
| +12% | +$8.48M |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.